应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NAUT Nautilus Biotechnolgy, Inc.
盘前交易 01-13 06:56:52 EST
1.99
-0.07
-3.40%
最高
2.07
最低
1.93
成交量
13.92万
今开
2.05
昨收
2.06
日振幅
6.80%
总市值
2.51亿
流通市值
9,210万
总股本
1.26亿
成交额
27.57万
换手率
0.30%
流通股本
4,628万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%
市场透视 · 2025-11-22
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%报2.54美元
市场透视 · 2025-11-20
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%报2.54美元
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.00%报2.00美元
市场透视 · 2025-11-19
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.00%报2.00美元
Nautilus Biotechnology, Inc.盘中异动 临近午盘急速拉升5.26%报1.40美元
市场透视 · 2025-11-04
Nautilus Biotechnology, Inc.盘中异动 临近午盘急速拉升5.26%报1.40美元
诺特勒斯2025财年Q3业绩会总结及问答精华:Tau蛋白检测与市场热情推动增长
业绩会速递 · 2025-10-29
诺特勒斯2025财年Q3业绩会总结及问答精华:Tau蛋白检测与市场热情推动增长
Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序
美股速递 · 2025-10-28
Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序
Nautilus Biotechnology, Inc.盘中异动 早盘股价大涨5.74%
市场透视 · 2025-10-27
Nautilus Biotechnology, Inc.盘中异动 早盘股价大涨5.74%
Nautilus Biotechnology, Inc.盘中异动 早盘急速跳水5.53%报0.840美元
市场透视 · 2025-10-14
Nautilus Biotechnology, Inc.盘中异动 早盘急速跳水5.53%报0.840美元
Nautilus Biotechnology, Inc.2025财年第二财季实现净利润-15.03百万美元,同比增加16.55%
市场透视 · 2025-08-09
Nautilus Biotechnology, Inc.2025财年第二财季实现净利润-15.03百万美元,同比增加16.55%
Nautilus Biotechnology, Inc.盘中异动 大幅上涨5.02%
市场透视 · 2025-08-07
Nautilus Biotechnology, Inc.盘中异动 大幅上涨5.02%
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%
市场透视 · 2025-07-30
Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%
Nautilus Biotechnology, Inc.盘中异动 下午盘大幅拉升5.30%报0.798美元
市场透视 · 2025-07-29
Nautilus Biotechnology, Inc.盘中异动 下午盘大幅拉升5.30%报0.798美元
Nautilus Biotechnology, Inc.盘中异动 股价大跌5.40%报0.745美元
市场透视 · 2025-07-16
Nautilus Biotechnology, Inc.盘中异动 股价大跌5.40%报0.745美元
Nautilus Biotechnology, Inc.盘中异动 快速跳水5.33%
市场透视 · 2025-03-11
Nautilus Biotechnology, Inc.盘中异动 快速跳水5.33%
Nautilus Biotechnology, Inc.2024财年实现净利润-70.78百万美元,同比减少11.15%
市场透视 · 2025-03-08
Nautilus Biotechnology, Inc.2024财年实现净利润-70.78百万美元,同比减少11.15%
Nautilus Biotechnology, Inc.盘中异动 下午盘快速下跌5.00%报1.14美元
市场透视 · 2025-03-07
Nautilus Biotechnology, Inc.盘中异动 下午盘快速下跌5.00%报1.14美元
Nautilus Biotechnology, Inc.盘中异动 股价大涨6.41%报1.25美元
市场透视 · 2025-02-28
Nautilus Biotechnology, Inc.盘中异动 股价大涨6.41%报1.25美元
Nautilus Biotechnology, Inc.盘中异动 股价大跌11.89%报1.26美元
市场透视 · 2025-02-27
Nautilus Biotechnology, Inc.盘中异动 股价大跌11.89%报1.26美元
鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)
财报速递 · 2025-02-27
鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)
Nautilus Biotechnology, Inc.盘中异动 股价大涨6.25%
市场透视 · 2025-02-14
Nautilus Biotechnology, Inc.盘中异动 股价大涨6.25%
加载更多
公司概况
公司名称:
Nautilus Biotechnolgy, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nautilus Biotechnology, Inc.是特拉华州的一家公司。他们是一家处于发展阶段的生命科学公司,致力于创建用于量化和解锁人类蛋白质组复杂性的平台技术。他们的使命是通过使蛋白质组的访问民主化并实现人类健康和医学的根本进步来改变蛋白质组学领域。他们认为,现有技术的渐进式进步是不够的,需要进行大胆的科学飞跃才能彻底改造蛋白质组学并彻底改变精准医学。他们的愿景是整合他们在计算机科学、工程和生物化学方面的突破性创新,以开发和商业化具有极高灵敏度和规模的蛋白质组学分析技术。为了实现这一目标,他们建立了一个单分子仪器的原型,即他们的蛋白质组学分析系统,该系统将得到进一步开发,以提供他们认为建立新的黄金标准所必需的速度、简单性、准确性和多功能性场地。
发行价格:
--
{"stockData":{"symbol":"NAUT","market":"US","secType":"STK","nameCN":"Nautilus Biotechnolgy, Inc.","latestPrice":1.99,"timestamp":1768251600000,"preClose":2.06,"halted":0,"volume":139208,"delay":0,"floatShares":46279068,"shares":126305122,"eps":-0.498074,"marketStatus":"盘前交易","change":-0.07,"latestTime":"01-13 06:56:52 EST","open":2.05,"high":2.07,"low":1.93,"amount":275704.22816,"amplitude":0.067961,"askPrice":2.49,"askSize":100,"bidPrice":0.796,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.498074,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768314600000},"marketStatusCode":1,"adr":0,"listingDate":1596772800000,"exchange":"NASDAQ","adjPreClose":1.99,"postHourTrading":{"tag":"盘后","latestPrice":1.97,"preClose":1.99,"latestTime":"17:18 EST","volume":5313,"amount":10330.42,"timestamp":1768256308224},"volumeRatio":0.5346310005125241,"impliedVol":1.5158,"impliedVolPercentile":0.588},"requestUrl":"/m/hq/s/NAUT","defaultTab":"news","newsList":[{"id":"2585345129","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585345129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585345129?lang=zh_cn&edition=full","pubTime":"2025-11-22 00:28","pubTimestamp":1763742539,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日00时28分,Nautilus Biotechnology, Inc.股票出现波动,股价急速拉升5.44%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122002900a7096c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122002900a7096c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2585190598","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585190598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585190598?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:55","pubTimestamp":1763650513,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时55分,Nautilus Biotechnology, Inc.股票出现异动,股价大幅上涨5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为1.45%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Annexon, Inc.、Design Therapeutics, Inc.涨幅较大,Psyence Biomedical Ltd.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为959.86%、39.19%、14.94%,振幅较大的相关个股有Biorestorative Therapies, Inc.、Seres Therapeutics, Inc.、康乃德生物,振幅分别为21.68%、20.85%、20.32%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120225513a4af849e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120225513a4af849e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2584991078","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.00%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584991078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584991078?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:57","pubTimestamp":1763485076,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时57分,Nautilus Biotechnology, Inc.股票出现异动,股价急速拉升5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Olema Pharmaceuticals, Inc.、Yd Bio Ltd C/Wts 28/08/2030、Iterum Therapeutics Plc涨幅较大,Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Galmed Pharmaceuticals Ltd.较为活跃,换手率分别为1924.34%、1106.26%、373.84%,振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd,振幅分别为106.34%、60.49%、59.39%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005757950c9b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005757950c9b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2580409789","title":"Nautilus Biotechnology, Inc.盘中异动 临近午盘急速拉升5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580409789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580409789?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:30","pubTimestamp":1762187436,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时30分,Nautilus Biotechnology, Inc.股票出现异动,股价急速上涨5.26%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为1.63%。其相关个股中,Terns Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、Phio Pharmaceuticals Corp.涨幅较大,Phio Pharmaceuticals Corp.、Tharimmune, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为2354.30%、555.65%、365.63%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Phio Pharmaceuticals Corp.,振幅分别为142.59%、129.83%、66.82%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400303697516108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400303697516108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"1198960781","title":"诺特勒斯2025财年Q3业绩会总结及问答精华:Tau蛋白检测与市场热情推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1198960781","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198960781?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:11","pubTimestamp":1761689478,"startTime":"0","endTime":"0","summary":"公司计划在2026年上半年推出Tau蛋白检测的早期访问计划,并在2026年底进行全面商业化。研发费用为960万美元,同比下降22%。净亏损为1360万美元,较2024年同期的1640万美元有所减少。公司现金、现金等价物和投资总额为1.685亿美元,预计现金流可支持运营至2027年。渠道建设正在进行中,预计2026年第一季度将进行首次商业招聘。诺特勒斯在2025年第三季度取得了显著进展,特别是在其蛋白质组学平台的外部验证方面。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT"],"gpt_icon":0},{"id":"1159354358","title":"Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1159354358","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159354358?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:11","pubTimestamp":1761646311,"startTime":"0","endTime":"0","summary":"Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2578939376","title":"Nautilus Biotechnology, Inc.盘中异动 早盘股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939376?lang=zh_cn&edition=full","pubTime":"2025-10-27 22:16","pubTimestamp":1761574610,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日22时16分,Nautilus Biotechnology, Inc.股票出现异动,股价急速拉升5.74%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、戴纳基、Avidity Biosciences, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Aditxt, Inc.、Cellectar Biosciences, Inc.较为活跃,换手率分别为147.75%、133.45%、123.48%,振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Fate Therapeutics, Inc.、冠科美博,振幅分别为31.00%、23.63%、19.22%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102722165094e0191e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102722165094e0191e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2575218942","title":"Nautilus Biotechnology, Inc.盘中异动 早盘急速跳水5.53%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575218942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575218942?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:37","pubTimestamp":1760449046,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时37分,Nautilus Biotechnology, Inc.股票出现异动,股价急速下挫5.53%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为2000.85%、19.95%、16.98%,振幅较大的相关个股有Genprex, Inc.、Pmgc Holdings Inc.、Osr Holdings, Inc.,振幅分别为25.72%、16.31%、15.67%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213726a6b916c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213726a6b916c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2558392576","title":"Nautilus Biotechnology, Inc.2025财年第二财季实现净利润-15.03百万美元,同比增加16.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558392576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558392576?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:01","pubTimestamp":1754668864,"startTime":"0","endTime":"0","summary":"8月9日,Nautilus Biotechnology, Inc.公布财报,公告显示公司2025财年第二财季净利润为-15.03百万美元,同比增加16.55%;其中营业收入为0.00美元,每股基本收益为-0.12美元。机构评级:截至2025年8月9日,当前有1家机构对Nautilus Biotechnology, Inc.目标价做出预测,其中目标均价为2.50美元,其中最低目标价为2.50美元,最高目标价为2.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000219a6db5667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000219a6db5667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT"],"gpt_icon":0},{"id":"2557309384","title":"Nautilus Biotechnology, Inc.盘中异动 大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557309384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557309384?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:46","pubTimestamp":1754498777,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日00时46分,Nautilus Biotechnology, Inc.股票出现异动,股价快速上涨5.02%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,Biomx Inc.、Avidity Biosciences, Inc.、Equillium, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为681.37%、405.57%、90.13%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc C/Wts 10/12/2026 ,振幅分别为57.18%、47.86%、45.47%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807004617a4791ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807004617a4791ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2555390023","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555390023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555390023?lang=zh_cn&edition=full","pubTime":"2025-07-30 23:22","pubTimestamp":1753888958,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日23时22分,Nautilus Biotechnology, Inc.股票出现波动,股价大幅拉升5.44%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.58%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073023223894c42471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073023223894c42471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2555923705","title":"Nautilus Biotechnology, Inc.盘中异动 下午盘大幅拉升5.30%报0.798美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555923705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555923705?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:42","pubTimestamp":1753724555,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日01时42分,Nautilus Biotechnology, Inc.股票出现异动,股价大幅拉升5.30%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Celcuity Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大,Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃,换手率分别为534.48%、299.44%、132.20%,振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为158.93%、82.93%、75.48%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729014235a4681e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729014235a4681e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2551194089","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌5.40%报0.745美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194089","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194089?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:56","pubTimestamp":1752609392,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时56分,Nautilus Biotechnology, Inc.股票出现波动,股价快速下挫5.40%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为1.15%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3875.95%、2230.99%、1572.60%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为444.11%、116.77%、77.14%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603563297a7714c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071603563297a7714c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2518277937","title":"Nautilus Biotechnology, Inc.盘中异动 快速跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277937?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:12","pubTimestamp":1741623169,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时12分,Nautilus Biotechnology, Inc.股票出现异动,股价快速下挫5.33%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃,换手率分别为3682.99%、3106.33%、934.80%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.,振幅分别为88.14%、78.32%、49.87%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一个平台技术,用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"gpt_icon":0},{"id":"2517458105","title":"Nautilus Biotechnology, Inc.2024财年实现净利润-70.78百万美元,同比减少11.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517458105?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363244,"startTime":"0","endTime":"0","summary":"3月8日,Nautilus Biotechnology, Inc.公布财报,公告显示公司2024财年净利润为-70.78百万美元,同比减少11.15%;其中营业收入为0.00美元,每股基本收益为-0.56美元。机构评级:截至2025年3月8日,当前有3家机构对Nautilus Biotechnology, Inc.目标价做出预测,其中目标均价为2.17美元,其中最低目标价为1.00美元,最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT"],"gpt_icon":0},{"id":"2517928381","title":"Nautilus Biotechnology, Inc.盘中异动 下午盘快速下跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517928381?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:36","pubTimestamp":1741289806,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时36分,Nautilus Biotechnology, Inc.股票出现波动,股价快速跳水5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一个平台技术,用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0},{"id":"2514320017","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.41%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320017?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分,Nautilus Biotechnology, Inc.股票出现异动,股价大幅上涨6.41%。截至发稿,该股报1.25美元/股,成交量6775股,换手率0.01%,振幅0.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一个平台技术,用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4121","BK4007","NAUT"],"gpt_icon":0},{"id":"2514386241","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌11.89%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386241?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:30","pubTimestamp":1740666624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分,Nautilus Biotechnology, Inc.股票出现波动,股价快速下挫11.89%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一个平台技术,用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAG","NAUT","BK4121","BK4139"],"gpt_icon":0},{"id":"1110538525","title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","url":"https://stock-news.laohu8.com/highlight/detail?id=1110538525","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110538525?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:38","pubTimestamp":1740659934,"startTime":"0","endTime":"0","summary":"鹦鹉螺生物科技报告的季度每股亏损为$,比分析师普遍预期的$好12.5%,与去年同期持平。以上内容来自Benzinga Earnings专栏,原文如下:Nautilus Biotechnology reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is unchanged from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT"],"gpt_icon":0},{"id":"2511457979","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511457979?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:23","pubTimestamp":1739474607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时23分,Nautilus Biotechnology, Inc.股票出现波动,股价大幅拉升6.25%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中,整体涨幅为1.17%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大,Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3183.07%、1982.56%、1233.56%,振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为733.31%、95.15%、92.30%。Nautilus Biotechnology, Inc.公司简介:Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司,创建了一个平台技术,用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nautilus.bio","stockEarnings":[{"period":"1week","weight":0.0529},{"period":"1month","weight":0.0757},{"period":"3month","weight":1.1159},{"period":"6month","weight":1.6579},{"period":"1year","weight":0.1307},{"period":"ytd","weight":0.0205}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nautilus Biotechnology, Inc.是特拉华州的一家公司。他们是一家处于发展阶段的生命科学公司,致力于创建用于量化和解锁人类蛋白质组复杂性的平台技术。他们的使命是通过使蛋白质组的访问民主化并实现人类健康和医学的根本进步来改变蛋白质组学领域。他们认为,现有技术的渐进式进步是不够的,需要进行大胆的科学飞跃才能彻底改造蛋白质组学并彻底改变精准医学。他们的愿景是整合他们在计算机科学、工程和生物化学方面的突破性创新,以开发和商业化具有极高灵敏度和规模的蛋白质组学分析技术。为了实现这一目标,他们建立了一个单分子仪器的原型,即他们的蛋白质组学分析系统,该系统将得到进一步开发,以提供他们认为建立新的黄金标准所必需的速度、简单性、准确性和多功能性场地。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.024892},{"month":2,"riseRate":0.6,"avgChangeRate":0.045091},{"month":3,"riseRate":0.6,"avgChangeRate":0.004911},{"month":4,"riseRate":0.2,"avgChangeRate":-0.103794},{"month":5,"riseRate":0.6,"avgChangeRate":-0.003176},{"month":6,"riseRate":0.2,"avgChangeRate":-0.022509},{"month":7,"riseRate":0.6,"avgChangeRate":-0.017062},{"month":8,"riseRate":0.2,"avgChangeRate":-0.079652},{"month":9,"riseRate":0.5,"avgChangeRate":0.010868},{"month":10,"riseRate":0.333333,"avgChangeRate":0.046365},{"month":11,"riseRate":0.5,"avgChangeRate":0.048822},{"month":12,"riseRate":0.5,"avgChangeRate":-0.033204}],"exchange":"NASDAQ","name":"Nautilus Biotechnolgy, Inc.","nameEN":"Nautilus Biotechnolgy, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nautilus Biotechnolgy, Inc.,NAUT,Nautilus Biotechnolgy, Inc.股票,Nautilus Biotechnolgy, Inc.股票老虎,Nautilus Biotechnolgy, Inc.股票老虎国际,Nautilus Biotechnolgy, Inc.行情,Nautilus Biotechnolgy, Inc.股票行情,Nautilus Biotechnolgy, Inc.股价,Nautilus Biotechnolgy, Inc.股市,Nautilus Biotechnolgy, Inc.股票价格,Nautilus Biotechnolgy, Inc.股票交易,Nautilus Biotechnolgy, Inc.股票购买,Nautilus Biotechnolgy, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}